SCHEMBL17504058

SCHEMBL17504058

Cc1csc(C[S+]([O-])C(c2ccccc2)c2ccccc2)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.39
▸ RAB9A P51151 2/20 0.36
▸ LMNA P02545 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ ADAMTS5 Q9UNA0 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ GRM5 P41594 1/20 0.36
▸ SLC6A3 Q01959 6/20 0.35
▸ NR3C1 P04150 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ PDE10A Q9Y233 1/20 0.33
▸ ADORA2A P29274 1/20 0.32
▸ ADORA1 P30542 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ THRB P10828 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21462611 0.82 SLC6A3 (0.32) SLC6A3
SCHEMBL17504082 0.77 SLC6A3 (0.54) LMNAKMT2ASMN1; SMN2GAAGRM5
SCHEMBL17504062 0.76 SLC6A3 (0.49) RAB9ALMNASLC6A3NR3C1NPC1
SCHEMBL21462390 0.74 SLC6A3 (0.37) SLC6A3
SCHEMBL17504087 0.72 SLC6A3 (0.52) RAB9ALMNASMN1; SMN2GAASLC6A3
SCHEMBL2056290 0.71 HDAC1 (0.51) RAB9ALMNAKMT2ASMN1; SMN2ADAMTS5
SCHEMBL21462404 0.71 SLC6A3 (0.35) SLC6A3
SCHEMBL17504073 0.71 SLC6A3 (0.51) LMNAKMT2ASMN1; SMN2SLC6A3MAPK1
SCHEMBL17504095 0.70 SLC6A3 (0.60) POLBRAB9ALMNAKMT2ASMN1; SMN2
SCHEMBL17504094 0.70 SLC6A3 (0.41) LMNASMN1; SMN2GAASLC6A3L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3553053-A1 (S)-ENANTIOMERIC FORM OF A HETEROCYCLIC COMPOUND HAVING MOTIVATION IMPROVING AND/OR REFERENCE MEMORY ENHANCING ACTIVITY Red Bull GmbH (AT) 2019-10-16 — — EP claimed
US-10221147-B2 Heterocyclic compounds with working memory enhancing activity RED BULL GMBH (AT) 2019-03-05 — — US claimed
EP-2985279-B1 Heterocyclic compounds with working memory enhancing activity RED BULL GMBH (AT) 2017-08-02 — — EP claimed
US-20170174642-A1 HETEROCYCLIC COMPOUNDS WITH WORKING MEMORY ENHANCING ACTIVITY COGMOTIV FLEXCO (AT) 2017-06-22 — — US claimed
EP-2985279-A1 Heterocyclic compounds with working memory enhancing activity Red Bull GmbH (AT) 2016-02-17 — — EP claimed
US-20260098095-A1 ANTIBODIES BINDING TO HLA-A2/MAGE-A4 HOFFMANN LA ROCHE (US) 2026-04-09 — — US disclosed
US-20250376412-A1 IGUS AND WINDOWS HAVING BOROSILICATE GLASS AND METHODS OF THE SAME CORNING INC (US) 2025-12-11 — — US disclosed
US-20250318282-A1 SOLAR DEVICES WITH BOROSILICATE GLASS AND METHODS OF THE SAME CORNING INCORPORATED 2025-10-09 — — US disclosed
US-20250037790-A1 DEGRON AND NEOSUBSTRATE IDENTIFICATION MONTE ROSA THERAPEUTICS AG (CH) 2025-01-30 — — US disclosed
US-20250011218-A1 GLASS WITH UNIQUE FRACTURE BEHAVIOR FOR VEHICLE WINDSHIELD CORNING INCORPORATED 2025-01-09 — — US disclosed
US-20240383987-A1 ANTIBODIES BINDING TO HLA-A2/MAGE-A4 HOFFMANN LA ROCHE (US) 2024-11-21 — — US disclosed
US-12122714-B2 Glass with unique fracture behavior for vehicle windshield CORNING INCORPORATED (US) 2024-10-22 — — US disclosed
US-20220184926-A1 GLASS WITH UNIQUE FRACTURE BEHAVIOR FOR VEHICLE WINDSHIELD CORNING INCORPORATED 2022-06-16 — — US disclosed
US-20220081530-A1 A SURFACE-TREATED FILLER MATERIAL PRODUCT PROVIDING IMPROVED UV STABILITY FOR POLYMERIC ARTICLES OMYA INTERNATIONAL AG (CH) 2022-03-17 — — US disclosed
US-20210380545-A1 (S)-ENANTIOMERIC FORM OF A HETEROCYCLIC COMPOUND HAVING MOTIVATION IMPROVING AND/OR REFERENCE MEMORY ENHANCING ACTIVITY RED BULL GMBH (AT) 2021-12-09 — — US disclosed
US-10221147-B2 Heterocyclic compounds with working memory enhancing activity RED BULL GMBH (AT) 2019-03-05 — — US disclosed
EP-2985279-B1 Heterocyclic compounds with working memory enhancing activity RED BULL GMBH (AT) 2017-08-02 — — EP disclosed
US-20170174642-A1 HETEROCYCLIC COMPOUNDS WITH WORKING MEMORY ENHANCING ACTIVITY COGMOTIV FLEXCO (AT) 2017-06-22 — — US disclosed
WO-2016023997-A1 HETEROCYCLIC COMPOUNDS WITH WORKING MEMORY ENHANCING ACTIVITY RED BULL GMBH (AT) 2016-02-18 — — WO disclosed
EP-2985279-A1 Heterocyclic compounds with working memory enhancing activity Red Bull GmbH (AT) 2016-02-17 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170174642-A1 HETEROCYCLIC COMPOUNDS WITH WORKING MEMORY ENHANCING ACTIVITY TAAR1, ACHE, RIF1 POLB 4472/4885RAB9A 475/4885LMNA 4275/4885
US-20210380545-A1 (S)-ENANTIOMERIC FORM OF A HETEROCYCLIC COMPOUND HAVING MOTIVATION IMPROVING AND/OR REFERENCE MEMORY ENHANCING ACTIVITY TFEB, TAAR1, RABGGTB POLB 4046/4885RAB9A 101/4885LMNA 4383/4885
US-10221147-B2 Heterocyclic compounds with working memory enhancing activity TAAR1, ACHE, RIF1 POLB 4472/4885RAB9A 475/4885LMNA 4275/4885
US-20260098095-A1 ANTIBODIES BINDING TO HLA-A2/MAGE-A4 HLA-DRB1, MICA, HLA-A POLB 1286/4885RAB9A 2339/4885LMNA 2331/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback